endpts.com·Apr 27, 2026
Veradermics has successfully completed its first major trial as a public company, demonstrating that its oral version of Rogaine effectively promotes hair growth in a late-stage trial.
There is no relevant insight from this content for a professional interested in healthtech, biotech, digital health, telemedicine, or AI drug discovery, as it primarily discusses Veradermics' success with an oral Rogaine in a late-stage trial.